Wenqing Yang - State Key Lab Translat Med & Innovat Drug Dev, Jiangsu Simcere Pharmaceut Co Ltd

基本信息

浏览量：5

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 72 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Technical Considerations and Strategies for Generating and Optimizing Humanized Mouse Tumor Models in Immuno-Oncology Research

Wenjing Li, Chunlei Xia, Kun Wang,Liting Xue,Yan Wang, Janine Y. Yang,Mingkun Zhang,Ming Yin,Zhenchuan Miao, Ying Li,Xiaofeng Zhao, Zhijian Yang,Renhong Tang,Wenqing Yang

International Immunopharmacology (2024): 112722-112722

引用0浏览0WOS引用

Generation and Application of a Robust Humanized Mouse Tumor Model System for Evaluation of NK-Targeting Therapeutics

Feng Lu, Weiqun Ding, Guangliang Yang, Yaoqing Jia, Zhaoxiang Wang, Xusheng Yuan,Ming Yin, Zhijian Yang,WenQing Yang

CANCER RESEARCHno. 7 (2024)

引用0浏览0引用

Abstract 3474: Identification of the Selective CBL-b Inhibitors Which Effectively Prevent T Cells from Exhaustion and Demonstrate Synergistic Anti-Tumor Activity in Combination with an Anti-Pd1 Antibody

Feng Zhou,Zhengtao Li, Yajing Liu,Guimei Yang,Wansun Mai,Wenqing Yang,Liting Xue,Ping Chen,Renhong Tang

Cancer Researchno. 7_Supplement (2023): 3474-3474

引用0浏览0引用

Abstract P5-02-53: P95HER2 Expression in HER2-Positive Breast Cancer

Chih Wan Goh,Liyi Zhang,Wei-Ru Chi,Bingqiu Xiu,Jiajian Chen,Wenqing Yang,Chunxia Ao,Jianxing Tang,Jingyan Xue,Yayun Chi,Jiong Wu

Cancer researchno. 5_Supplement (2023): P5-53

引用0浏览0引用

Abstract 6201: Identification of SP-002, a Highly Selective USP1 Inhibitor Effectively Inhibits HRD Tumor Growth and Displays Low Hematotoxicity Risk

Feng Zhou,Zhengtao Li,Lei Zhou, Wei Zhu, Jiyan Zhang,Wenqing Yang,Liting Xue, Xiaokang Qin,Ping Chen,Renhong Tang

Cancer Researchno. 7_Supplement (2023): 6201-6201

引用0浏览0引用

P95HER2 Expression in HER2-Positive Breast Cancer

Chih Wan Goh,Liyi Zhang,Wei-Ru Chi,Bingqiu Xiu,Jiajian Chen,Wenqing Yang,Chunxia Ao,Jianxing Tang,Jingyan Xue,Yayun Chi,Jiong Wu

CANCER RESEARCHno. 5 (2023)

引用0浏览0引用

Supplementary Figure 1 from Identification of Nuclear Export Inhibitors with Potent Anticancer Activity <i>in Vivo</i>

Sarah C. Mutka,Wen Qing Yang,Steven D. Dong,Shannon L. Ward,Darren A. Craig,Pieter B.M.W.M. Timmermans,Sumati Murli

crossref（2023）

引用0浏览0引用

Supplementary Methods and Materials from Identification of Nuclear Export Inhibitors with Potent Anticancer Activity <i>In vivo</i>

Sarah C. Mutka,Wen Qing Yang,Steven D. Dong,Shannon L. Ward,Darren A. Craig,Pieter B.M.W.M. Timmermans,Sumati Murli

crossref（2023）

引用0浏览0引用

Identification of SS008871, a Novel Pol. Inhibitor That Effectively Inhibits Tumors with Homologous Recombination Deficiency in Vitro and in Vivo

Feng Zhou,Lu Liu,Lei Jiang,Feng Tang,Zhen Li,Wenqing Yang,Liting Xue, L. Chen,Renhong Tang

CANCER RESEARCHno. 7 (2023)

引用0浏览0引用

SCR-8388, a Potent and Selective SOS1::KRAS Inhibitor, is Effective in KRAS-addicted Cancers

Feng Zhou,Guimei Yang, Tang,Yan Zhang, Shengwei Yang,Wenqing Yang,Liting Xue,Ping Chen,Renhong Tang

CANCER RESEARCHno. 7 (2023)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn